Health In Tech, Inc. Class A (HIT) AI Stock Analysis

• Market Cap: $64.88M
• Dividend Yield: N/A
• Average Volume (3M): 482.27K
• Price to Earnings (P/E): 45.4
• Beta (1Y): 1.79
• Revenue Growth: 55.15%
• EPS Growth: -22.92%
• Country: US
• Employees: 73
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 0.01
• Shares Outstanding: 45,208,810
• 10 Day Avg. Volume: 553,509
• 30 Day Avg. Volume: 482,269
• PEG Ratio: -6.86
• Price to Book (P/B): 27.29
• Price to Sales (P/S): 18.44
• P/FCF Ratio: 281.76
• Enterprise Value/Market Cap: 2.79
• Enterprise Value/Revenue: 5.88
• Enterprise Value/Gross Profit: 8.77
• Enterprise Value/Ebitda: 68.66
• 1Y Price Target: $4.50
• Price Target Upside: 204.05% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 0.02
• Revenue Forecast (FY): $31.61M

• Rating: 66 Neutral
• Price Target: $1.00 ▼(-32.43% Downside)

Health In Tech, Inc. shows strong financial performance and positive earnings call sentiment, indicating potential for growth. However, technical indicators suggest bearish momentum, and the stock appears overvalued. These factors result in a moderate overall stock score.

Positive Factors

Revenue Growth

The significant year-over-year revenue growth indicates strong market demand and effective sales strategies, positioning the company for continued expansion.

Distribution Network Expansion

Expanding the distribution network enhances market penetration and product accessibility, supporting long-term revenue growth and competitive positioning.

Blockchain Initiative

The HITChain initiative could improve claims processing efficiency and transparency, providing a competitive edge and operational improvements.

Negative Factors

Market Uncertainty

Market uncertainties and rising costs may delay customer decision-making, potentially impacting sales volumes and revenue predictability.

High Administrative Costs

High administrative costs can strain profitability and limit resources for growth initiatives, necessitating cost management improvements.

Earnings Conversion

Challenges in converting earnings into free cash flow may limit financial flexibility and investment capacity, impacting long-term growth potential.

Health In Tech, Inc. Class A Business Overview & Revenue Model

Company Description

Health In Tech, Inc. Class A (HIT) is a pioneering company operating at the intersection of healthcare and technology. Focused on delivering innovative solutions, HIT specializes in developing advanced digital health platforms, telemedicine services, and health analytics tools. The company's core offerings include a suite of applications that enhance patient engagement, streamline communication between healthcare providers, and leverage artificial intelligence to improve clinical decision-making. Committed to transforming the healthcare landscape, HIT serves a diverse clientele that includes hospitals, clinics, and insurance providers.

How the Company Makes Money

Health In Tech, Inc. generates revenue through multiple streams. The primary revenue model is subscription-based, where healthcare providers and organizations pay monthly or annual fees for access to HIT's digital health platforms and services. Additionally, HIT earns income from transaction fees associated with its telemedicine services, where patients are charged for virtual consultations. The company also monetizes its analytics tools by offering premium features and insights to healthcare organizations seeking to enhance their operational efficiency. Strategic partnerships with healthcare providers and technology companies further bolster HIT's earnings, allowing for co-development of solutions and expanding market reach.

Health In Tech, Inc. Class A Financial Statement Overview

Summary

Health In Tech, Inc. demonstrates strong financial performance with robust revenue growth and efficient cost management. The balance sheet reflects a conservative financial structure with low leverage and solid equity returns. Cash flow generation is healthy, although there is room for improvement in converting earnings into free cash flow.

Income Statement

Health In Tech, Inc. shows strong revenue growth with a significant increase in total revenue over the TTM period. The gross profit margin remains robust, indicating efficient cost management. However, the net profit margin is moderate, suggesting room for improvement in profitability. The EBIT and EBITDA margins are healthy, reflecting operational efficiency.

Balance Sheet

The company maintains a low debt-to-equity ratio, indicating prudent financial leverage. Return on equity is solid, showcasing effective use of equity to generate profits. The equity ratio is stable, reflecting a balanced capital structure. However, the relatively low total assets compared to equity suggest limited asset utilization.

Cash Flow

Operating cash flow is strong, with a good coverage ratio over net income, indicating healthy cash generation from operations. Free cash flow growth is positive, but the free cash flow to net income ratio suggests potential constraints in converting profits into free cash flow. Overall, cash flow management is effective but could be optimized further.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022
Income Statement
Total Revenue	30.72M	19.49M	19.15M	5.77M
Gross Profit	20.61M	15.44M	16.85M	5.44M
EBITDA	2.63M	1.93M	3.76M	205.58K
Net Income	1.44M	670.48K	2.48M	79.74K
Balance Sheet
Total Assets	22.76M	15.77M	11.50M	28.56M
Cash, Cash Equivalents and Short-Term Investments	8.02M	7.85M	2.42M	1.49M
Total Debt	157.60K	206.69K	1.92M	316.09K
Total Liabilities	5.60M	2.60M	5.41M	27.14M
Stockholders Equity	17.16M	13.17M	6.09M	1.05M
Cash Flow
Free Cash Flow	1.55M	1.28M	384.52K	-436.63K
Operating Cash Flow	2.15M	2.18M	1.53M	782.75K
Investing Cash Flow	-2.90M	-836.75K	-1.94M	-1.22M
Financing Cash Flow	7.03M	4.09M	1.34M	1.88M

Health In Tech, Inc. Class A Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.48
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HIT, the sentiment is Negative. The current price of 1.48 is below the 20-day moving average (MA) of 1.62, below the 50-day MA of 2.53, and below the 200-day MA of 2.07, indicating a bearish trend. The MACD of -0.36 indicates Negative momentum. The RSI at 28.31 is Positive, neither overbought nor oversold. The STOCH value of 11.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HIT.

Health In Tech, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HIT	66 Neutral	$64.88M	45.42	11.94%	―	55.15%	-22.92%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
WFCF	60 Neutral	$65.18M	24.97	27.34%	―	-1.17%	43.94%
RSSS	59 Neutral	$101.23M	81.70	9.49%	―	5.83%	―
SSTI	44 Neutral	$86.22M	―	-14.61%	―	-1.83%	-642.89%

Health In Tech, Inc. Class A Corporate Events

Health In Tech Extends Lock-Up Restrictions Post-IPO

On December 2, 2025, Health In Tech announced that its executive management team, vice presidents, and Board of Directors have voluntarily extended the lock-up restrictions on their shares for an additional six months, until June 20, 2026. This decision, following the company’s IPO in December 2024, reflects the leadership’s confidence in the company’s growth prospects and ongoing initiatives in technology and market expansion.

Health In Tech Announces Investor Presentation Preparation

On November 10, 2025, Health In Tech, Inc. announced the preparation of an investor presentation to be presented at conferences and meetings. The company has signed a non-binding Letter of Intent with AlphaTON Capital Corp. to develop HITChain, a blockchain-enabled healthcare insurance claims processing platform. This strategic partnership aims to address inefficiencies, fraud, and opacity in the U.S. healthcare market, targeting over $300 billion in annual claims administration costs. The initiative is expected to enhance the company’s operational efficiency and industry positioning, potentially impacting stakeholders positively by reducing administrative costs and improving trust.

Health In Tech Reports 90% Revenue Growth in Q3

On November 10, 2025, Health In Tech announced its financial results for the third quarter ending September 30, 2025, reporting a significant revenue increase of 90% year-over-year to $8.5 million. The company also highlighted its strategic initiatives, including the launch of large-employer underwriting within its eDIYBS platform and a non-binding LOI with AlphaTON Capital to develop a blockchain-powered claims platform. These developments aim to expand Health In Tech’s market presence and address inefficiencies in the U.S. healthcare claims administration, positioning the company at the forefront of decentralized healthcare infrastructure.

Health In Tech Reports 90% Revenue Increase in Q3 2025

On November 10, 2025, Health In Tech, Inc. held a conference call to discuss its Q3 2025 financial results, reporting a 90% year-over-year revenue increase to $8.5 million, driven by an expanded distribution network. The company launched a large-employer underwriting capability and announced a blockchain-enabled platform, HITChain, in collaboration with AlphaTON Capital Corp., aiming to improve claims processing efficiency. Health In Tech will host the InsurTech Summit in Davos during the World Economic Forum week in January 2026, highlighting its role in the global innovation stage.